Tags: Drug.

Relcovaptan (SR-49059) is a non-peptide vasopressin receptor antagonist selective for the V1a subtype. It has shown positive initial results in tests against Raynaud’s disease dysmenorrhoea and tocolysis although it is not yet approved for clinical use.

Relcovaptan.png
ATC prefix
none
CAS number
150375-75-0
FDA UNII code
C1GL8G6G0O
IUPAC name
1-((2R3S)-5-chloro-3-(2-chlorophenyl)-1-[(34-dimethoxyphenyl)sulfonyl]-3-hydroxy-23-dihydro-1H-indol-2-ylcarbonyl)-(L)-prolinamide
PubChem
60943

Loading...

This page contains content from the copyrighted Wikipedia article "Relcovaptan"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.